欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2022, Vol. 27 ›› Issue (3): 253-259.doi: 10.12092/j.issn.1009-2501.2022.03.002

• 基础研究 • 上一篇    下一篇

SIRT3在右美托咪定减轻小鼠肠缺血再灌注损伤中的作用及机制

任以行1,2,冷玉芳1,郭名君1,张健民1,石亚静1,陈 凤1,刘 馨1   

  1. 1兰州大学第一医院,兰州 730000,甘肃;2苏州大学附属第二医院,苏州 215004,江苏
  • 收稿日期:2021-06-21 修回日期:2021-11-09 出版日期:2022-03-26 发布日期:2022-04-11
  • 通讯作者: 冷玉芳,女,博士,教授/主任医师,研究方向:器官保护。 E-mail: lengyf@lzu.edu.cn
  • 作者简介:任以行,男,硕士,住院医师,研究方向:器官保护。 E-mail: 17755552134@163.com
  • 基金资助:
    国家自然科学基金(81960345);甘肃省自然科学基金(21JR1RA069);兰州大学第一医院院内基金(ldyyyn2019-25)

Role and mechanism of SIRT3 in attenuation of intestinal ischemia-reperfusion injury by dexmedetomidine in mice

REN Yixing1,2, LENG Yufang1, GUO Mingjun1, ZHANG Jianmin1, SHI Yajing1, CHEN Feng1, LIU Xin1   

  1. 1The First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China; 2Department of Anesthesiology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu, China
  • Received:2021-06-21 Revised:2021-11-09 Online:2022-03-26 Published:2022-04-11

摘要: 目的:探讨沉默信息调节因子2同源蛋白3(SIRT3)在右美托咪定减轻小鼠肠缺血再灌注损伤中的作用及机制。方法:健康雄性C57BL小鼠24只,随机分为4组(n=6):假手术组(Sham组)、肠缺血再灌注组(I/R组)、右美托咪定组(Dex组)及SIRT3抑制剂3-TYP组(3-TYP组)。Sham组仅进行假手术,其余三组通过夹闭肠系膜上动脉45 min再灌注2 h制备肠缺血再灌注模型。于缺血前1 h时,3-TYP组腹腔注射3-TYP(5 mg/kg,稀释至0.3 mL),其余三组腹腔注射0.3 mL生理盐水;于缺血前30 min时,3-TYP组和Dex组均腹腔注射右美托咪定(25 μg/kg,稀释至0.3 mL),其余两组分别腹腔注射0.3 mL生理盐水。再灌注2 h时麻醉下处死小鼠,取肠组织,HE染色后在光镜下观察病理学变化,并进行Chiu's肠损伤评分;分光光度法测定SIRT3活性、超氧化物歧化酶2(SOD2)活性、丙二醛(MDA)含量。结果:与Sham组相比,I/R组、Dex组、3-TYP组病理学损伤加重,Chiu's评分升高,MDA含量增多,SIRT3活性水平与SOD2活性水平降低(P<0.05)。与I/R组相比,Dex组、3-TYP组病理学损伤减轻,Chiu's评分降低(P<0.05)。与I/R组相比,Dex组MDA含量减少,SIRT3活性水平与SOD2活性水平升高(P<0.05),3-TYP组MDA含量、SIRT3活性水平与SOD2活性水平均无统计学差异。与Dex组相比,3-TYP组病理学损伤加重,Chiu's评分升高,MDA含量增多,SIRT3活性水平与SOD2活性水平降低(P<0.05)。 结论:SIRT3及其下游SOD2参与介导右美托咪定通过抑制氧化应激反应减轻小鼠肠缺血再灌注损伤的作用。

关键词: SIRT3, 氧化应激反应, 右美托咪定, 再灌注损伤,

Abstract: AIM: To explore the role and mechanism of silent mating type information regulator 2 homolog 3 (SIRT3) in attenuation of intestinal ischemia-reperfusion (I/R) injury by dexmedetomidine in mice. METHODS: Twenty-four healthy male C57BL mice were divided into 4 groups randomly (n=6): sham operation group (Sham group), intestinal ischemia-reperfusion group (I/R group), dexmedetomidine group (Dex group), SIRT3 inhibitor 3-TYP group (3-TYP group). Superior mesenteric artery was clamped for 45 min followed by reperfusion for 2 h to establish intestinal I/R model in I/R group, Dex group, and 3-TYP group. Sham group received sole sham operation. 1 h prior to onset of ischemia, 3-TYP was injected into mice in 3-TYP group intraperitoneally (5 mg/kg, diluted to 0.3 mL), and 0.3 mL normal saline into mice in Dex group intraperitoneally. 30 min prior to onset of ischemia, dexmedetomidine was injected into mice in 3-TYP group and Dex group intraperitoneally (25 μg/kg, diluted to 0.3 mL). 1 h and 30 min prior to onset of ischemia, 0.3 mL normal saline was injected into mice in Sham group and I/R group intraperitoneally, respectively. 2 h of after reperfusion, the mice were sacrificed under anesthesia. Intestinal tissues were took and observed for pathological changes under light microscope after HE staining, and the injury was assessed via the Chiu's score method, and activities of SIRT3 and superoxide dismutase 2 (SOD2)   were detected via spectrophotometry, and malondialdehyde (MDA) via spectrophotometry. RESULTS: The pathological injury was exacerbated, and the Chiu's score, the MDA level elevated remarkably, while the activity level of SIRT3 and SOD2 declined remarkably in I/R group, Dex group and 3-TYP group compared to Sham group (P<0.05). The pathological injury was alleviated, and the Chiu's score declined remarkably in Dex group and 3-TYP group compared to I/R group (P<0.05); and the MDA level declined remarkably, while activity level of SIRT3 and SOD2 elevated remarkably in Dex group compared to I/R group (P<0.05); and there was no significant difference both in the activity level of SIRT3 and SOD2 and in the MDA level between 3-TYP group and I/R group. The pathological injury was exacerbated, and the Chiu's score, the MDA level elevated remarkably, while the activity level of SIRT3 and SOD2 declined remarkably in 3-TYP group compared to Dex group (P<0.05). CONCLUSION: SIRT3 and its downstream SOD2 are involved in mediating the effect of attenuation of intestinal ischemia-reperfusion injury through inhibiting oxidative stress response by dexmedetomidine.

Key words: SIRT3, oxidative stress response, dexmedetomidine, reperfusion injury, intestine

中图分类号: